Sfoglia per Afferenza Dipartimento di Medicina clinica, sanità pubblica, scienze della vita e dell'ambiente
Interference of antisperm antibodies with the induction of the acrosome reaction by zona pellucida (ZP) and its relationship with the inhibition of ZP binding
1997-01-01 Francavilla, Felice; Romano, R; Santucci, R; Marrone, V; Properzi, Giuliana; Ruvolo, G.
Interferenze della terapia antalgica con le risposte cardiocircolatorie al trauma.
1996-01-01 Ciccozzi, Alessandra; Varrassi, G.
The interhemispheric transcallosal-transversal approach to the lesions of the anterior and middle third ventricle: surgical validity and neuropsychological evaluation of the outcome
2004-01-01 Mazza, Monica; Di Renzo, A; Costagliola, C; Roncone, Rita; Casaccia, M; Ricci, A; Galzio, Renato
Interleuckin-2 and 13-CIS retinoic acid as treatment of ovarian cancer stem cells
2009-01-01 Recchia, F; Camdeloro, G; Necozione, S; Bisegna, R; Carta, Gaspare; Rea, S.
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis
2008-01-01 Vincenzi, B; Patti, G; Galluzzo, S; Pantano, F; Venditti, O; Santini, D; Ruzzo, A; Schiavon, G; Caraglia, M; Marra, M; Graziano, F; Tonini, G
Interleukin 2 (Il2) production and Il2 receptor release in type I diabetes
1989-01-01 Cavallo, Mg; Signore, A; Baroni, M. G.; Andreani, D; Pozzilli, P
Interleukin 7 engineered stromal cells: a new approach for hastening naive T cell recruitment
2005-01-01 DI IANNI, Mauro; DEL PAPA, B; DE IOANNI, M; Terenzi, A; Sportoletti, P; Moretti, L; Falzetti, F; Gaozza, E; Zei, T; Spinozzi, F; Bagnis, C; Mannoni, P; Bonifacio, E; Falini, B; Martelli, Mf; Tabilio, A.
Interleukin 7 retroviral gene transfer in human stromal cells enhances th survival of naive T lymphocytes
2003-01-01 DI IANNI, Mauro; B., Del Papa; M., De Ioanni; P., Sportoletti; L., Moretti; E., Ayroldi; F., Falzetti; Martelli, M. F.; A., Tabilio
Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model
2018-01-01 Gabellini, C.; Gomez-Abenza, E.; Ibanez-Molero, S.; Tupone, M. G.; Perez-Oliva, A. B.; de Oliveira, S.; Del Bufalo, D.; Mulero, V.
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction
2005-01-01 Patti, G; Mega, S; Pasceri, V; Nusca, A; Giorgi, G; Zardi, Em; D'Ambrosio, A; Dobrina, A; Di Sciascio, G
Interleukin-1 receptor antagonist: A sensitive marker of instability in patients with coronary artery disease
2002-01-01 Patti, G; D'Ambrosio, A; Dobrina, A; Dicuonzo, G; Giansante, C; Fiotti, N; Abbate, A; Guarnieri, G; Di Sciascio, G
Interleukin-18 in obese children and adolescents: new marker of inflammation and endothelial cell activation
2007-01-01 De Simone, M; Iezzi, Ml; Desideri, Giovambattista; Ferri, Claudio; Raiola, G; Pellegrino, K; Pezone, I.
Interleukin-1beta specifically stimulates nitric oxide production in the hypothalamus
1996-01-01 Brunetti, L; Volpe, ANNA RITA; Ragazzoni, E; Preziosi, P; Vacca, M.
Interleukin-1beta stimulates nitric oxide release from cultured rat hypothalamic cells in vitro
1995-01-01 L., Brunetti; Volpe, ANNA RITA; E., Ragazzoni; P., Preziosi; M., Vacca
Interleukin-1beta-producing plasma cells in close contact with hepatocytes in patients with chronic active hepatitis
1997-01-01 Hassan, G; Moreno, S; Massimi, Mara; DI BIAGIO, P; Stefanini, S.
. Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong disease-free and overall survival in patients with non small cell lung cancer (NSCLC) responsive to chemotherapy. J Clin Oncol 2005: 23, 234s (supplement), abstract #3171.
2005-01-01 Recchia, F; Saggio, G; Cesta, A; Candeloro, G; Nuzzo, A; Lombardo, M; Rea, Silvio
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong clinical benefit in patients with advanced solid tumors showing a partial response (PR) or stable disease (SD) to chemotherapy. J Clin Oncol 2005: 2, 27s (supplement).
2005-01-01 Saggio, G; Cesta, A; Amiconi, G; Di Blasio, A; Candeloro, G; Alesse, E; Rea, Silvio
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) dicrease serum vascular endothelial growth factor (VEGF) of patients with platinum sensitive, advanced ovarian cancer (AOC)
2005-01-01 Recchia, F; Cesta, A; Candeloro, G; Saggio, G; Nuzzo, A; Lalli, A; Lombardo, M; Carta, Gaspare; Rea, S.
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) prolong disease- free and overall survival in recurrent ovarian cancer (ROC).Annals of Oncology, 2004, 15: 131, abstract # 491P.
2004-01-01 F., Recchia; G., Saggio; A., Cesta; A., Nuzzo; Carta, Gaspare; Rea, Silvio
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) prolong disease-free and overall survival in recurrent ovarian cancer (ROC)
2004-01-01 Recchia, F; Saggio, G; Cesta, A; Nuzzo, A; Carta, Gaspare; Rea, S.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile